MAG1C presentation at the External Researcher CMVD summit

Dr. Nicklas Järvelä Johansen presented the MAG1C Study to endocrinologists and cardiologists at the External Researcher CMVD Summit in Rome hosted by AstraZeneca on 23 November 2017.

Dr. Nicklas Järvelä Johansen presented his MAG1C-project.

The MAG1C Study looks into add-on treatment of Byetta, a blood-glucose-lowering drug used with good results in type-2-diabetes treatment for more than 10 years, to intensive insulin treatment in persons with type 1 diabetes.

The MAG1C study is made in collaboration between Steno Diabetes Center Copenhagen and Center for Diabetes Research, Gentofte Hospital. 

For more information about the MAG1C trial: